A new surgical robotic system is "feasible, safe, and effective" for treatment of early-stage prostate cancer, concludes an initial evaluation in The Journal of
Keck Medicine of USC study shows that the incidence rate of metastatic prostate cancer rose as much as 43% in men 75 and older and 41% in men 45-74 after routine prostate cancer screenings were no longer recommended